PEFTEC 2019 Rotterdam: May 22–23
PETROLEUM, REFINING & ENVIRONMENTAL TECHNOLOGIES CONFERENCE EXHIBITION & SEMINARS
22nd – 23rd MAY 2019 – ROTTERDAM, THE NETHERLANDS
PETROLEUM, REFINING & ENVIRONMENTAL TECHNOLOGIES CONFERENCE EXHIBITION & SEMINARS
22nd – 23rd MAY 2019 – ROTTERDAM, THE NETHERLANDS The conferences at PEFTEC 2019 are titled –
From Crude to Customer - Developments in Analysis for the Petro Industry Supply Chain which will feature a keynote lecture by Ryan P. Rodgers who is one of the godfathers of Petroleomics and Director of the Future Fuels Institute at Florida State University.
In addition to an exhibition and series of free-to-attend seminars, PEFTEC 2019, The 3rd International Conference & Exhibition on Downstream, Petroleum, Refining and Environmental Technologies, taking place at the Ahoy Exhibition Centre in Rotterdam, The Netherlands, has announced that its Conference offer has been expanded yet again to include a dedicated Process Analysis Conference and “Big Data - Big Analysis” sessions, to compliment the popular Analytical Conference.
and Lasers, Light, Sensors and Separation - Tools and Techniques for Process Based Analysis which includes a keynote from Alison Nordon from the Centre for Process Analysis and Control Technology (CPACT) which will be followed by sessions on process gas analysis using online techniques such as GC, Optical Feedback Cavity Enhanced Absorption Spectroscopy, VUV Spectroscopy and Open Path FTIR.
Who should attend?
If you are involved in the generation, provision, application and use of analytical data and instrumentation in the petroleum processing, refining and petrochemical space then the conferences and exhibition will have plenty to interest you. On the laboratory front the two day conference “From Crude to Customer - Developments in Analysis for the Petro Industry Supply Chain” covers a wide range of current research and application topics from the feed crude through to final products. The on-line and in-field process analysis conference “Lasers, Light, Sensors and Separation - Tools and Techniques for Process Based Analysis” will run in parallel over the 2 days covering the latest developments in process- based spectroscopy, chromatography, sensors and advanced data processing and analytics.
In addition, both conferences will feature special sessions on the hot topic of big data and big analysis which will consider strategies, tools and techniques to maximise the value derived
from the vast quantities of analytical and process data now routinely available to the industry.
The conferences programmes have been designed to be complementary and delegates will be free to move between the two to mix and match topics of specific interest to them.
For more information visit
www.ilmexhibitions.com
48686pr@reply-direct.com
Fisher Scientific Channel Names Corning Life Sciences as European Supplier of the Year
The event, themed ‘Gaining Advantage’, included an exhibition showcase with 62 booths featuring laboratory products from Thermo Fisher Scientific and other leading suppliers, and it culminated in a gala dinner and awards ceremony, during which Thermo Fisher recognised and rewarded the efforts of exemplary colleagues and supplier partners.
The winning suppliers are confirmed as follows: • European Supplier of the Year - Corning Life Sciences
• European Supply Chain Award - Thermo Fisher Scientific Biosciences Business
• European e-Business Excellence Award - Bürkle • European Private Label Supplier of the Year - Ansell • European Extraordinary Growth Award - DWK Life Sciences
Thermo Fisher Scientific recently announced the winners of the Fisher Scientific Channel Supplier Awards during its annual Fisher Scientific European Sales Conference held in Poland.
From 4-7 March 2019, almost 750 delegates attended the Fisher Scientific European Sales Conference at the Golebiewski Hotel, Karpacz, Poland. This was the eighth event of its kind, bringing together delegates from 21 different countries.
• European Marketing Support Award - GE Healthcare Life Sciences
• European Sales Support Award - Thermo Fisher Scientific Laboratory Chemicals Business
• European Supplier Best Booth - Sartorius • European Rising Supplier Star - Binder • European Excellence Award - Sartorius
Tammy Starr, Vice President, Sales, Fisher Scientific Channel, Europe, commented: “In 2019, I’m Gaining Advantage by collaborating with our internal functions and suppliers to take market share.”
More information online:
ilmt.co/PL/vXYR 48662pr@reply-direct.com
Diagnostic Clues Found for PAH
affecting around 6,500 people in the UK. Caused by a narrowing of the arteries supplying blood to the lungs and leading to possible heart failure, PAH can occur spontaneously at any age.
Led by Dr Talat Nasim, in Bradford’s School of Pharmacy and Medical Sciences and including researchers from the University of Cambridge (UK), Kings College London (UK), University of Dhaka (Bangladesh), Centre for Health Agricultural and Socio-economic Advancements (CHASA, Bangladesh) and Hacettepe University (Turkey), the study* builds on earlier research to investigate the genetic causes of PAH – in particular the mechanism of one faulty gene known as BMPR-II, which was first identified nearly two decades ago.
Dr Talat Nasim
Researchers at the University of Bradford have identified a biomarker that could be used to provide earlier diagnosis for Pulmonary arterial hypertension (PAH), a life limiting condition
Dr Nasim explained: “We wanted to find out why the cells are not dying, but instead were building up inside the wall of the pulmonary arteries. To do this, we needed to identify and investigate the proteins that are influenced by this gene.”
The team discovered that the faulty BMPR-II gene affected one particular protein called Bcl-x. This, in turn, is responsible
for making two different proteins, one of which increases cell apoptosis and the other one reduces it. These two work in balance in the body to regulate cell death. If BMPR-II is faulty, however, the protein for reducing cell apoptosis is increased – preventing cell death from occurring. “This protein can be used as a biomarker for accurately identifying PAH in patients,” said Dr Nasim. “This could help us diagnose PAH at an earlier stage, possibly leading to better treatment options for patients. We can also make other services available, such as genetic counselling, to help patients understand the disease and to identify those at risk of developing it.”
Dr Nasim’s team has filed a patent for the biomarker and is now investigating whether it could also be a target for new drugs. A number of promising compounds are currently being developed and tested.
*Published in Human Molecular Genetics
48687pr@reply-direct.com
TO BE INCLUDED IN OUR NEXT ISSUE, SEND ALL YOUR RESEARCH AND EVENTS NEWS STORIES TO
HEATHER@INTLABMATE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
